Institutional Investors Bet on Nike's Recovery Amid Stock Slump

Major funds aggressively buy Nike shares as stock hits 52-week lows, signaling a potential disconnect between market price and long-term confidence ahead of Q3 earnings.

As Nike's share price touches new lows, a notable divergence is emerging behind the scenes. Major institutional investors are significantly increasing their stakes in the sportswear giant ahead of its upcoming quarterly earnings report. This growing confidence from financial professionals, set against a backdrop of weak price performance, offers a fresh perspective on the company's outlook.

A Clash Between Market Price and Investor Action

The optimism of analysts and large investors stands in stark contrast to the current trading reality. Just last Friday, the stock hit a new 52-week low of €45.41, bringing its year-to-date decline to nearly 16 percent. The company's consistent dividend payments, supported by the steady cash flow of the $77 billion corporation, have so far failed to convince the broader market to buy in.

All eyes are now on Tuesday, March 31, when Nike is scheduled to release its results for the third fiscal quarter of 2026 after the US market closes. This event will provide the fundamental data needed to reconcile the current disconnect between the weak stock performance and the targeted acquisitions by institutional players.

Major Funds Are Building Positions

More than 64 percent of Nike shares are now held by institutional investors. The aggressive purchasing activity of several prominent funds in recent disclosures is particularly striking:

• Exchange Traded Concepts LLC boosted its holdings by almost 700 percent.
• Coldstream Capital Management increased its position by 50 percent.
• Soros Fund Management LLC grew its stake by 33 percent.

This accumulation is mirrored in shifting sentiment on Wall Street. In March, Barclays upgraded its rating from "Equal Weight" to "Overweight," simultaneously raising its price target. The Royal Bank of Canada continues to maintain its "Outperform" recommendation. Market experts appear to be placing greater faith in the management's strategic initiatives to fuel a turnaround.